MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Commerzbank Goes Live With Misys Risk Vision 5.4, Following a Successful, On Schedule Implementation Project

— LONDON, April 10

LONDON, April 10 /PRNewswire/ -- Misys plc (LSE: MSY), the global application software and services company, today announces that Commerzbank has gone live on the latest version of Misys Risk Vision, following a successful project to extend the capability of the solution for the bank.

Over 900 employees at Commerzbank now use the enhanced risk management solution from Misys to gather and analyse the local and global exposure to credit risk across the entire business.

"Misys Risk Vision provides us with a consolidated view of all credit exposures of activities in our trading and investment banking operations," comments Markus Rumpel, Global Credit Officer Financial Institutions from Commerzbank. "The advanced functionality in the latest version of the solution enables us to manage our global credit limit and exposures better and gives our traders better information to improve their decision making. We are delighted with the solution and the support from Misys which has allowed us to maintain our competitive edge and bring us the return on our investment we were looking for."

The majority of the users are directly involved in trading, based in Frankfurt, London, New York, Tokyo and Singapore. This is a trend that Misys is seeing in the demand for the enterprise risk management solution, as David Stewart, Risk Director, Misys Treasury & Capital Markets, states. "Misys Risk Vision is increasingly servicing the ever-growing need for risk functionality from our customers across the group. Traders have to make faster decisions on the risks associated with every transaction they make before the deal is executed and our solution brings the most thorough information available to them in the most rapid time."

Claus Schuenemann, Head of Sales Europe at Misys, points out: "Misys has developed Risk Vision to enhance the functionality to cater for the new demands of the customers. The improved capabilities available in Misys Risk Vision 5.4 allow banks to accelerate the time-to-market for the business, make use of all available risk mitigation techniques, such as collateralising and netting, and be able to integrate new instruments and delivery systems quickly adding real value to the trading desk."

About Misys plc

Misys plc (FTSE: MSY.L), provides integrated, comprehensive solutions that deliver significant results to organisations in the financial services and healthcare industries. We maximise value for our customers by combining our deep knowledge of their business with our commitment to their success.

In banking and treasury & capital markets, Misys is a market leader, with over 1,200 customers, including all of the world's top 50 banks. In healthcare, Misys is a market leader, serving more than 110,000 physicians in 18,000 practice locations and 600 home care providers. Misys employs around 4,500 people who serve customers in more than 120 countries.

We aspire to be the world's best application software and services company, delivering results for the most important industries in the world.

Misys: experience, solutions, results

Contact us today, visit: http://www.misys.com

For further information please contact: Edward Taylor Global Head of Public Relations Misys Banking +44(0)208-486-1661 edward.taylor@misys.com Caroline Parker Financial Dynamics +44(0)207-269-7295 caroline.parker@fd.com

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us